Palatin Technologies Inc. (NYSEMKT:PTN)

Palatin Technologies, Inc is a development-stage medical technology company involved in developing and commercializing products and technologies for diagnostic imaging, cancer therapy and ethical drug development These developments are based on its proprietary monoclonal antibody radiolabeling and enabling peptide platform technologies.

Palatin Technologies Inc. (NYSEMKT:PTN)’s Financial Overview

Palatin Technologies Inc. (NYSEMKT:PTN) surged 22.39% yesterday to close its trading session at $0.82. The company has 1 year Price Target of $5.67. Palatin Technologies Inc. has 52-Week high of $0.86 and 52-Week Low of $0.36. The stock touched its 52-Week High on Aug 1, 2016 and 52-Week Low on Mar 17, 2016. The stock traded with the volume of 7.44 Million shares yesterday. The firm shows the market capitalization of $88.58 Million.

Palatin Technologies Inc. (NYSEMKT:PTN) reported its last quarterly earnings on Jun 16 where the firm reported its Actual EPS of $-0.08/share against the analyst consensus estimate of $-0.06/share. The difference between the actual and expected EPS is $-0.02 a share with a surprise factor of -33.3%.

The firm is trading with SMA20 of 51.04 Percent, SMA50 of 46.11 Percent and SMA200 of 54.96 percent. Palatin Technologies Inc. has P/S value of 0 while its P/B value stands at 0. Similarly, the company has Return on Assets of -253.6 percent, Return on Equity of 572.6 percent and Return on Investment of 0 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.

Many brokerage firms are involved in issuing their ratings on Palatin Technologies Inc. (NYSEMKT:PTN). On 23-May-12 Noble Financial Initiated Palatin Technologies Inc. Stock  to Buy. Another firm also rated the stock on 23-Jan-07 where Next Generation Initiated the stock to Buy.

The Stock currently has Analyst’ mean Recommendation of 1.7 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 3 analysts offering 12-month price forecasts for Palatin Technologies Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +631.71% increase from the last price of 0.82.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

salesforce.com, inc. (NYSE:CRM)

Salesforce.com is the market and technology leader in on-demand business services. The company’s Salesforce suite of on-demand CRM applications allows customers to manage and share all of their sales, support, marketing and partner information on-demand. The Salesforce Platform, the world’s first on- demand platform, enables customers, developers and partners to build powerful new on-demand applications that extend beyond CRM to deliver the benefits of multi-tenancy and The Business Web across the enterprise. The Salesforce Platform allows applications to be easily shared, exchanged and installed with a few simple clicks via salesforce.com’s AppExchange directory. Customers can also take advantage of Successforce, salesforce.com’s world-class training, support, consulting and best practices offerings.

salesforce.com, inc. (NYSE:CRM)’s Financial Outlook

The 43 analysts offering 12-month price forecasts for Salesforce.com have a median target of 95.00, with a high estimate of 110.00 and a low estimate of 64.00. The median estimate represents a +30.26% increase from the last price of 72.93.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, salesforce.com, inc. has a Consensus Recommendation of 1.17. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock gained 0% and closed its last trading session at $72.93. The company has the market capitalization of $50.81 Billion. The stock has 52-week high of $84.48 and 52-Week low of $52.6. The firm touched its 52-Week high on May 26, 2016 and 52-Week low on Feb 8, 2016. The company has volume of 7.42 Million shares. The company has a total of 696.7 Million shares outstanding.

salesforce.com, inc. (NYSE:CRM) in the last quarter reported its actual EPS of $0.24/share where the analyst estimated EPS was $0.21/share. The difference between the actual and Estimated EPS is $0.03. This shows a surprise factor of 14.3 percent.

The company has YTD performance of -6.98 percent. Beta for salesforce.com, inc. stands at 1.48 while its ATR (average true range) is 1.76. The company has Weekly Volatility of 1.61%% and Monthly Volatility of 2.30%%.

salesforce.com, inc. has distance from 20-day Simple Moving Average (SMA20) of -2.53%, Distance from 50-Day Simple Moving Average of -0.76 percent and Distance from 200-Day Simple Moving Average of -3.99%.

The Company currently has ROA (Return on Assets) of 1.5 percent, Return on Equity (ROE) of 3.5 Percent and Return on Investment (ROI) of 0% with Gross margin of 74.1 percent and Operating & Profit margin of 1.3% and 2.6% respectively.